Specific downregulation of presenilin 2 gene expression is prominent during early stages of sporadic late-onset Alzheimer's disease

Molecular Brain Research

Volumn 78, Issue 1-2, 2000, Pages 138-145

  McMillan, Pamela J ^a   Leverenz, James B ^b   Dorsa, Daniel M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; Cerebellum; Gene expression; Hippocampus; Presenilin

Indexed keywords

PRESENILIN 2;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; FEMALE; FOREBRAIN; FRONTAL CORTEX; GENE EXPRESSION; GENE MUTATION; HIPPOCAMPUS; HUMAN; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN CHEMISTRY; CEREBELLUM; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PRESENILIN-2; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 0034737987     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00086-3     Document Type: Article

References (35)

1. M. Bobinski, J. Wegiel, H.M. Wisniewski, M. Tarnawski, B. Reisberg, B. Mlodzik et al., Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer's disease, Dementia 6 (1995) 205-210.
2. D.R. Borchelt, G. Thinakaran, C.B. Eckman, M.K. Lee, F. Davenport, T. Ratovitsky et al., Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo, Neuron 17 (1996) 1005-1013.
3. H. Braak, E. Braak, Neuropathological staging of Alzheimer-related changes, Acta Neuropathol. 82 (1991) 239-259.
4. M.C. Chartier-Harlin, F. Crawford, H. Houlden, A. Warren, D. Hughes, L. Fidani et al., Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene, Nature 353 (1991) 844-846.
5. D.H. Chui, H. Tanahashi, K. Ozawa, S. Ikeda, F. Checler, O. Ueda et al., Transgenic mice with Alzheimer's presenilin mutations show accelerated neurodegeneration without amyloid plaque formation, Nature Med. 5 (1999) 560-564.
6. M. Citron, D. Westaway, W. Xia, G. Carlson, T. Diehl, G. Levesque et al., Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice, Nature Med. 3 (1997) 67-72.
7. B. De Strooper, P. Saftig, K. Craessaerts, H. Vanderstichele, G. Guhde, W. Annaert et al., Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein, Nature 391 (1998) 387-390.
8. K. Duff, C. Eckman, C. Zehr, X. Yu, C.M. Prada, J. Perez-Tur et al., Increased amyloid-β42 (43) in brains of mice expressing mutant presenilin 1, Nature 383 (1996) 710-713.
9. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani et al., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991) 704-706, (see comments).
10. A. Herreman, D. Hartmann, W. Annaert, P. Saftig, K. Craessaerts, L. Serneels et al., Preselenin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency, Proc. Natl. Acad. Sci. USA 96 (1999) 11872-11877.
11. I. Ikeda, K. Urakami, K. Isoe, K. Ohno, K. Nakashima, The expression of preseniln-1 mRNA in skin fibroblasts from Alzheimer's disease, Dement. Geriatr. Cogn. Disord. 9 (1997) 145-148.
12. J.A. Johnston, S. Froelich, L. Lannfelt, R.F. Cowburn, Quantification of presenilin-1 mRNA in Alzheimer's disease brains, FEBS Lett 394 (1996) 279-284.
13. S. Kittur, J. Hoh, H. Endo, W. Tourtellotte, B.S. Weeks, W. Markesbery et al., Cytoskeletal neurofilament gene expression in brain tissue from Alzheimer's disease patients. I. Decrease in NF-L and NF-M message, J. Genat. Psych. Neurol. 7 (1993) 153-158.
14. D.M. Kovacs, H.J. Fausett, K.J. Page, T.W. Kim, R.D. Moir, D.E. Merriam et al., Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells, Nature Med. 2 (1996) 224-229.
15. H.C. Kraemer, J.L. Taylor, J.R. Tinklenberg, J.A. Yesavage, The stages of Alzheimer's disease: a reappraisal, Dement. Geriatr. Cogn. Disord. 9 (1998) 299-308.
16. E. Levy-Lahad, W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, W.H. Pettingell et al., Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science 269 (1995) 973-977, see comments.
17. C.F. Lippa, A.M. Saunders, T.W. Smith, J.M. Swearer, D.A. Drachman, B. Ghetti et al., Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a common pathway, Neurology 46 (1996) 406-412.
18. P.J. McMillan, J.B. Leverenz, P. Poorkaj, G.D. Schellenberg, D.M. Dorsa, Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's disease, J. Histochem. Cytochem. 44 (1996) 1215-1222.
19. M. Mullan, H. Houlden, M. Windelspecht, L. Fidani, C. Lombardi, P. Diaz et al., A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene, Nat. Genet. 2 (1992) 340-342.
20. J. Murrell, M. Farlow, B. Ghetti, M.D. Benson, A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease, Science 254 (1991) 97-99.
21. National Institute on Aging and Reagan Institute Working Group, Consensus recommendations for the postmortem diagnosis of Alzheimer's disease, Neurobiol. Aging 18 (1997) S1-S2.
22. K. Nishiyama, S. Murayama, T. Suzuki, Y. Mitsui, Y. Sakaki, I. Kanazawa, Presenilin 1 mRNA expression in hippocampi of sporadic Alzheimer's disease patients, Neurosci. Res. 26 (1996) 75-78.
23. L.M. Refolo, C. Eckman, C.M. Prada, D. Yager, K. Sambamurti, N. Mehta et al., Antisense-induced reduction of presenilin 1 expression selectively increases the production of amyloid β42 in transfected cells, J. Neurochem. 73 (1999) 2383-2388.
24. E.A. Rogaeva, R. Sherrington, E.A. Rogaeva, G. Levesque, M. Ikeda, Y. Liang et al., Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type-3 gene, Nature 376 (1995) 775-778.
25. A.M. Saunders, K. Schmader, J.C. Breitner, M.D. Benson, W.T. Brown, L. Goldfarb et al., Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases, Lancet 342 (1993) 710-711, (see comments).
26. A.M. Saunders, W.J. Strittmatter, D. Schmechel, R.H. St. George-Hyslop, M.A. Periak-Vance, S.H. Joo, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology 43 (1993) 1467-1472, (see comments).
27. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki et al., The amyloid β protein deposited in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nature Med. 2 (1996) 864-870.
28. J. Shen, R.T. Bronson, D.F. Chen, W. Xia, D.J. Selkoe, S. Tonegawa, Skeletal and CNS defects in presenilen-1-deficient mice, Cell 89 (1997) 629-639.
29. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, M. Ikeda et al., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature 375 (1995) 754-760, see comments.
30. H. Steiner, K. Duff, A. Capell, H. Romig, M.G. Grim, S. Lincoln et al., A loss of function mutation of presenilin-2 interferes with amyloid β-peptide production and Notch signaling, J. Biol. Chem. 274 (1999) 28669-28673.
31. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen et al., Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA 90 (1993) 1977-1981.
32. K. Takami, K. Terai, A. Matsuo, D.G. Walker, P.L. McGeer, Expression of presenilin-1 and -2 mRNA in rat and Alzheimer's disease brains, Brain Res. 748 (1997) 122-130.
33. T. Tomita, K. Maruyama, T.C. Saido, H. Kume, K. Shinozaki, S. Tokuhiro et al., The presenilin 2 mutation (N141I) linked to familial Alzheimer's disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue, Proc. Natl. Acad. Sci. USA 94 (1997) 2025-2030.
34. M.S. Wolfe, W. Xia, B.L. Ostaszewski, T.S. Diehl, W.T. Kimberly, D.J. Selkoe, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity, Nature 398 (1999) 513-517.
35. P.C. Wong, H. Zheng, H. Chen, M.W. Becher, D.J.S. Sirinathsinghji, M.E. Trumbauer et al., Presenilin 1 is required for Notch 1 and Dll 1 expression in the paraxial mesoderm, Nature 387 (1997) 288-292.